Boothbay Fund Management LLC Sells 41,518 Shares of Enovis Co. (NYSE:ENOV)

Boothbay Fund Management LLC cut its stake in Enovis Co. (NYSE:ENOV - Free Report) by 29.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 99,198 shares of the company's stock after selling 41,518 shares during the period. Boothbay Fund Management LLC owned 0.17% of Enovis worth $4,353,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Quadrant Capital Group LLC boosted its position in Enovis by 53.0% during the 4th quarter. Quadrant Capital Group LLC now owns 690 shares of the company's stock valued at $30,000 after acquiring an additional 239 shares in the last quarter. Amalgamated Bank lifted its position in Enovis by 1.0% in the 4th quarter. Amalgamated Bank now owns 25,887 shares of the company's stock valued at $1,136,000 after acquiring an additional 264 shares in the last quarter. Pinnacle Bancorp Inc. lifted its position in Enovis by 54.5% in the 4th quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company's stock valued at $37,000 after acquiring an additional 300 shares in the last quarter. Arizona State Retirement System raised its stake in Enovis by 2.6% during the 4th quarter. Arizona State Retirement System now owns 16,208 shares of the company's stock valued at $711,000 after buying an additional 414 shares during the last quarter. Finally, UMB Bank n.a. raised its stake in Enovis by 128.2% during the 4th quarter. UMB Bank n.a. now owns 778 shares of the company's stock valued at $34,000 after buying an additional 437 shares during the last quarter. 98.45% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC restated a "buy" rating and issued a $64.00 price objective on shares of Enovis in a research note on Wednesday, April 9th.

Enovis Price Performance

Enovis stock traded down $0.34 during mid-day trading on Wednesday, hitting $34.57. The stock had a trading volume of 757,227 shares, compared to its average volume of 756,162. The firm has a market capitalization of $1.97 billion, a P/E ratio of -15.79 and a beta of 1.86. The company has a current ratio of 2.27, a quick ratio of 1.12 and a debt-to-equity ratio of 0.40. The firm's 50 day moving average is $36.13 and its 200 day moving average is $41.91. Enovis Co. has a one year low of $29.32 and a one year high of $56.43.

Enovis (NYSE:ENOV - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.98 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.92 by $0.06. The business had revenue of $560.98 million for the quarter, compared to the consensus estimate of $555.14 million. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. On average, sell-side analysts forecast that Enovis Co. will post 2.79 earnings per share for the current fiscal year.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.